Castle biosciences posts q2 loss per share of $0.08

Castle biosciences announces second quarter 2020 results.q2 revenue rose 18 percent to $12.7 million.q2 revenue estimate $8.8 million -- refinitiv ibes data.qtrly loss per share $0.08.q2 earnings per share view $-0.40 -- refinitiv ibes data.

CSTL Ratings Summary

CSTL Quant Ranking